XML 72 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Total Varex Equity
Noncontrolling Interests
Common stock, shares, outstanding, beginning balance (in shares) at Sep. 28, 2018   38,000,000.0          
Stockholders' equity, beginning balance at Sep. 28, 2018 $ 428.3 $ 0.4 $ 357.6 $ 5.8 $ 62.4 $ 426.2 $ 2.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss 8.6       8.8 8.8 (0.2)
Exercise of stock options 0.1   0.1     0.1  
Common stock issued upon vesting of restricted shares (in shares)   200,000          
Shares withheld on vesting of restricted stock (in shares)   (100,000)          
Shares withheld on vesting of restricted stock (2.1)   (2.1)     (2.1)  
Common stock issued under employee stock purchase plan (in shares)   100,000          
Common stock issued under employee stock purchase plan 1.9   1.9     1.9  
Share-based compensation 5.6   5.6     5.6  
Unrealized loss on interest rate swap contracts, net of tax (3.7)     (3.7)   (3.7)  
Common stock, shares, outstanding, ending balance (in shares) at Mar. 29, 2019   38,200,000          
Stockholders' equity, ending balance at Mar. 29, 2019 435.2 $ 0.4 363.1 2.1 67.7 433.3 1.9
Common stock, shares, outstanding, beginning balance (in shares) at Dec. 28, 2018   38,100,000          
Stockholders' equity, beginning balance at Dec. 28, 2018 429.2 $ 0.4 362.1 3.5 61.3 427.3 1.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss 5.8       5.8 5.8  
Exercise of stock options 0.1   0.1     0.1  
Common stock issued upon vesting of restricted shares (in shares)   200,000          
Common stock issued upon vesting of restricted shares 0.0            
Shares withheld on vesting of restricted stock (in shares)   (100,000)          
Shares withheld on vesting of restricted stock (2.1)   (2.1)     (2.1)  
Share-based compensation 3.0   3.0     3.0  
Unrealized loss on interest rate swap contracts, net of tax (1.4)     (1.4)   (1.4)  
Common stock, shares, outstanding, ending balance (in shares) at Mar. 29, 2019   38,200,000          
Stockholders' equity, ending balance at Mar. 29, 2019 $ 435.2 $ 0.4 363.1 2.1 67.7 433.3 1.9
Common stock, shares, outstanding, beginning balance (in shares) at Sep. 27, 2019 38,371,305 38,400,000          
Stockholders' equity, beginning balance at Sep. 27, 2019 $ 448.2 $ 0.4 371.8 (1.7) 74.4 444.9 3.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (3.3)       (3.2) (3.2) (0.1)
Exercises of stock options (in shares) 64,000 100,000          
Exercise of stock options $ 1.5   1.5     1.5  
Common stock issued upon vesting of restricted shares (in shares)   200,000          
Common stock issued upon vesting of restricted shares 0.0            
Shares withheld on vesting of restricted stock (in shares)   (100,000)          
Shares withheld on vesting of restricted stock (1.8)   (1.8)     (1.8)  
Common stock issued under employee stock purchase plan (in shares)   100,000          
Common stock issued under employee stock purchase plan 1.8   1.8     1.8  
Share-based compensation 6.5   6.5     6.5  
Unrealized loss on interest rate swap contracts, net of tax (2.3)     (2.3)   (2.3)  
Currency translation adjustments 4.3     4.3   4.3  
Other $ (0.3)   (0.3)     (0.3)  
Common stock, shares, outstanding, ending balance (in shares) at Apr. 03, 2020 38,653,547 38,700,000          
Stockholders' equity, ending balance at Apr. 03, 2020 $ 454.3 $ 0.4 379.5 0.3 70.9 451.1 3.2
Common stock, shares, outstanding, beginning balance (in shares) at Jan. 03, 2020   38,500,000          
Stockholders' equity, beginning balance at Jan. 03, 2020 451.2 $ 0.4 377.6 (2.6) 72.5 447.9 3.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (2.0)       (1.9) (1.9) (0.1)
Exercise of stock options 0.3   0.3     0.3  
Common stock issued upon vesting of restricted shares (in shares)   200,000          
Common stock issued upon vesting of restricted shares 0.0            
Shares withheld on vesting of restricted stock (1.7)   (1.7)     (1.7)  
Share-based compensation 3.3   3.3     3.3  
Unrealized loss on interest rate swap contracts, net of tax (2.3)     (2.3)   (2.3)  
Currency translation adjustments $ 5.2     5.2   5.2  
Common stock, shares, outstanding, ending balance (in shares) at Apr. 03, 2020 38,653,547 38,700,000          
Stockholders' equity, ending balance at Apr. 03, 2020 $ 454.3 $ 0.4 $ 379.5 $ 0.3 $ 70.9 $ 451.1 $ 3.2